Are Your Eye Tests Being Interpreted Together

This is one of the most consequential gaps in eye care. Individual tests read in isolation. Findings not connected across appointments. A pattern that is obvious in retrospect, invisible in the moment. Your eye tests must be interpreted together, explains Dr Shibal Bhartiya.

Your visual field test showed some changes. Your pressure was slightly elevated last year. Your optic nerve photograph “looked a little different.” Each time, you were told it was probably nothing to worry about. Each time, it was a single finding, noted, filed, and moved on from.

But what if those findings, taken together, over time, tell a different story?

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Eye Tests Need to Be Interpreted Together

A Single Test Result Is a Data Point. A Series Is Evidence.

One intraocular pressure reading of 22 mmHg may be a measurement variation. Three readings of 22, 24, and 23 mmHg across eighteen months is a pattern. One visual field with a small cluster defect may be noise. The same defect deepening across three tests is progression.

Glaucoma management is built on trends, not snapshots. A clinician reading only today’s result, without the context of last year’s, and the year before’s, is reading a single page of a long book and trying to summarise the plot.

Structural and Functional Tests Must Be Read Against Each Other

In glaucoma, two classes of test are essential: structural (optic nerve photographs, OCT — optical coherence tomography) and functional (visual field tests). Each has strengths and limitations.

Structural tests detect nerve fibre layer thinning before functional loss is measurable. Functional tests detect changes in how the visual system processes information. Neither tells the whole story alone. In early disease, structural tests are more sensitive. In moderate disease, functional tests become more revealing. A clinician who reads only one without the other is working with half the evidence.

Risk Factors Must Be Weighted Alongside Test Results

A pressure of 21 mmHg in a 35-year-old with no family history and thick corneas is clinically different from the same pressure in a 55-year-old with a first-degree relative who lost vision to glaucoma and thin corneas. The number is identical. The clinical significance is not.

Test results do not interpret themselves. They must be placed in the context of the individual: their age, their ethnicity, their family history, their previous measurements, their rate of change. When that context is missing, test results are misread.

The Rate of Change Matters as Much as the Absolute Value

A visual field that shows moderate damage but has been completely stable for five years carries a very different prognosis from a visual field showing mild damage that has been deteriorating steadily over the same period. The first patient has time. The second patient needs more aggressive management now.

Without longitudinal data, without tests being compared across time, this distinction cannot be made. A single visit cannot establish a rate of change. It can only establish a position.


Signs Your Tests May Not Be Being Integrated

  • Your results are described in isolation at each appointment, with no reference to previous findings
  • You have never been shown a trend graph of your pressures or visual field results
  • Your OCT and visual field results have never been discussed together
  • You have seen different doctors at each visit, with no single clinician holding your full history
  • You have never received a printed summary of your results to carry between appointments
  • Your risk factors have never been explicitly factored into the interpretation of your results

What Integrated Eye Care Actually Looks Like

At each appointment, a clinician reviewing your tests should:

  • Compare today’s findings with previous results from the same tests
  • Note whether structural and functional findings are concordant
  • Factor in your individual risk profile when interpreting borderline values
  • Calculate or estimate your rate of change if sufficient data exists
  • Explain not just what the tests show today, but what they show over time
  • State explicitly whether you are stable, uncertain, or showing change

Across appointments, you should:


Symptom and Situation

SituationWhat It SuggestsWhat to Ask
Results discussed only in isolationNo longitudinal review“How do these compare to my previous results?”
Different doctor each appointmentContinuity broken“Can I be reviewed by the same specialist each time?”
OCT and fields never discussed togetherIncomplete integration“What do these show when read alongside each other?”
Rate of change never mentionedTrend not being tracked“Am I stable, or have things changed?”
Risk factors not discussedContext missing from interpretation“How does my family history affect how you read this result?”
No printed results providedYou cannot carry your own history“Can I have a copy of all my results to date?”

What Doctors Often Miss

Integration takes time. In a busy clinic, the path of least resistance is to report today’s test and move on. Comparing results across visits requires pulling previous records, displaying trend data, and reasoning across time: all of which adds minutes to an appointment that is already short.

The patient who is stable and uncomplaining is the patient most at risk of this gap. When nothing seems urgently wrong, the careful work of longitudinal comparison is most likely to be skipped. And it is in that patient , the quiet, apparently stable one, that slow progression is most likely to be missed.


When to Act

Ask for integrated review if:

  • You have had more than two or three eye tests and no one has ever compared them explicitly
  • You have risk factors for glaucoma and your monitoring has felt episodic rather than continuous
  • A finding: pressure, disc appearance, field result, has been described as “borderline” or “to watch” without a specific follow-up plan
  • You are about to make a treatment decision and want to understand the full trajectory of your disease, not just the latest snapshot

What This Means for You

The value of eye testing is not in individual results. It is in the pattern those results form over time, read against each other and against your individual risk.

Ask your clinician: “How does this compare to last time?” Ask: “Are my structural and functional tests telling the same story?” Ask: “Am I stable?” These are not difficult questions. The answers are what you are owed.

If the answers are not there, because the data has not been compared, or because continuity has been broken, that is the moment to seek care from a specialist who will hold your full picture and read it as a whole.


Frequently Asked Questions

What is the difference between structural and functional tests in glaucoma?

Structural tests, optic nerve photography and OCT, measure the physical integrity of the optic nerve and retinal nerve fibre layer. Functional tests, visual field tests, measure what you can see across your field of vision. Both change in glaucoma, but at different rates and different stages. Reading them together gives a far more complete picture than either alone.

How many visual field tests are needed to detect a trend?

Reliable trend analysis typically requires a minimum of five to six visual field tests. Many specialists recommend performing tests more frequently in the first two years of diagnosis to establish the baseline rate of change. A single visual field or even two tests cannot establish whether a patient is stable or progressing.

What is target IOP and why does it matter?

Target IOP is the individualised pressure goal at which a clinician believes a specific patient’s glaucoma will not progress, or will progress so slowly as to have no functional impact within their lifetime. It is calculated based on the level of damage present, the rate of previous progression, age, and life expectancy. It is not a fixed number, it varies between patients and must be reassessed over time. If your doctor has not discussed a target pressure with you, ask what it is.

Can I request copies of all my eye test results?

Yes. You are entitled to copies of your own medical records, including all test printouts, OCT scans, visual field results, and clinical letters. Keeping a personal file of your results allows continuity even when you change clinics or see a different doctor. Always bring this file to any new consultation.

What should I do if I have had multiple tests but no one has ever compared them?

Bring all your results, printouts, photographs, reports, to a specialist consultation and ask explicitly for a longitudinal review. A fellowship-trained glaucoma specialist can often look at a sequence of tests and establish, within a single consultation, whether there has been change, at what rate, and what it means for your management.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Related Reading

Get an Online Glaucoma Consult

Why Do I Need a Visual Field Test?

Understanding Your OCT Report in Glaucoma

Visual Field and OCT: Structure & Function Correlation

Gonioscopy

Glaucoma Diagnosis in Gurgaon

Glaucoma Progression: What It Means and How to Slow It

Get a Glaucoma Second Opinion in Gurgaon

Avoid Glaucoma Surgery

Glaucoma can appear uncontrolled when medications are not being used consistently or correctly. Complex treatment schedules, poor eye drop technique, treatment fatigue, and medication side effects may raise eye pressure and mimic disease progression. A glaucoma second opinion can identify these issues before surgery is considered.

Not every patient with glaucoma needs surgery immediately. In many cases, improving eye drop technique, simplifying medications with fixed-dose combinations, or considering SLT laser treatment can achieve good pressure control and delay or avoid surgery. This is when a Glaucoma Second Opinion can help, says Dr Shibal Bhartiya.

A Word of Caution: Avoiding glaucoma surgery is NOT always advisable. In certain cases, the surgery is the only option, and helps prevent blindness. You must discuss the risks and benefits of your treatment protocol in detail with your glaucoma doctor before coming to a decision.

She Was Told She Needed Surgery

Anita, 63, had been living with glaucoma for nearly six years when she came to see me. At her previous appointment, surgery had been advised. Her eye pressure remained above target despite treatment, and recent visual field tests suggested possible progression. The changes were not dramatic, but they were concerning enough for surgery to enter the discussion.

She arrived carrying a large folder of records and four eye drop bottles.

As I reviewed her reports, I understood the concern. Her pressures were higher than ideal. A few visual field tests appeared slightly worse than earlier ones. Yet the optic nerve photographs showed only subtle change over time.

The clue had been present for months. I asked Anita to describe her treatment routine.

She was not avoiding treatment. She was trying very hard to follow it. The problem was that her regimen had gradually become more complicated. Four medications meant four separate bottles. Some needed morning doses. Others needed evening doses. During travel, one bottle might be forgotten. On busy days, she sometimes could not remember whether she had already used a drop.

Then I asked her to put in her medication. One drop landed on her cheek. Another missed the eye completely.

The glaucoma was real. The pressure problem was real. The possible progression was real.

But the patient was not failing treatment. The treatment plan was failing the patient. We simplified her regimen. Four separate medications became two fixed-dose combination bottles. We reviewed eye drop technique and built the schedule around her daily routine. Over the next three months, we achieved her target IOP, with the same medicines. Just in fewer bottles, and just because she learnt how to put them herself.

Over the last two years, her visual fields and RNFL OCT have been stable.

Patient details have been changed to protect privacy.

Here is What We Must Remember

Anita’s case highlights an important lesson. Not every patient with uncontrolled eye pressures needs glaucoma surgery. Sometimes the problem lies in how treatment is being delivered rather than the treatment itself. Glaucoma medications only work when they reach the eye consistently and correctly. Before treatment is escalated, it is important to understand whether the prescribed therapy is practical, tolerable, and sustainable. In this article, I explain why glaucoma treatment sometimes appears to fail and how a glaucoma second opinion can help.

Why Glaucoma Treatment Sometimes Appears To Fail

The goal of glaucoma treatment is simple. Lower eye pressure enough to prevent damage to the optic nerve. Achieving that goal is often more complicated.

Many patients begin treatment with a single eye drop. As glaucoma progresses, additional medications may be added. Over time, one bottle can become two, then three, then four. Each medication may have a different schedule.

For some patients, this becomes difficult to sustain.

In my practice, I commonly see patients who understand the importance of their medication but struggle with the practical realities of long-term treatment. Life gets busy. Travel happens. Schedules change. Even highly motivated patients miss doses.

Poor adherence does not always mean patients are careless. More often, it reflects treatment burden.

The clue had been present for almost a year in Anita’s case. Her pressure fluctuated more than expected. Her visual fields suggested borderline progression. Yet the optic nerve remained relatively stable. The pattern suggested that treatment effectiveness might be inconsistent.

When treatment appears to fail, specialists should ask several questions:

  • Is the diagnosis correct?
  • Is the target pressure appropriate?
  • Is the medication reaching the eye?
  • Is the patient able to follow the regimen?
  • Are side effects reducing adherence?

The answers can significantly change management.

The Importance of Eye Drop Technique

Many patients have never been shown how to use an eye drop correctly.

Common mistakes include:

  • Missing the eye completely
  • Blinking immediately after instillation
  • Using multiple drops at once
  • Touching the bottle tip to the eye
  • Administering medications too close together

Even small technique errors can reduce treatment effectiveness.

A simple demonstration often reveals problems that no scan or visual field test can detect.

Why Fixed-Dose Combinations Matter

Fixed-dose combinations combine two glaucoma medications into a single bottle.

Many patients assume these combinations are prescribed for convenience alone. In reality, they often improve treatment success.

A patient using four medications in four separate bottles may struggle with timing, scheduling, and adherence. The same medications delivered through two fixed-dose combinations can reduce confusion and simplify daily routines.

Fewer bottles often mean:

  • Better adherence
  • Less treatment fatigue
  • Lower preservative exposure
  • Greater long-term consistency

The most effective treatment is not always the strongest treatment. Often, it is the treatment a patient can realistically follow every day for years.

Could Laser Treatment Reduce the Need for Eye Drops?

For some patients, Selective Laser Trabeculoplasty (SLT) offers another way to lower eye pressure without adding more medications. SLT is a quick outpatient laser procedure that improves the eye’s natural drainage system. It does not cure glaucoma, but it can reduce eye pressure and, in some patients, decrease the number of medications needed.

This can be particularly helpful for patients who struggle with eye drop schedules, experience side effects from medications, or find long-term adherence difficult. While not every patient is a suitable candidate, SLT is increasingly being used earlier in the treatment pathway because it avoids many of the compliance challenges associated with daily eye drops. A glaucoma specialist can determine whether SLT is appropriate based on the type of glaucoma, eye pressure targets, and the overall risk of progression.

This is why a glaucoma second opinion should not focus only on surgery versus medications. For selected patients, laser treatment may offer an effective middle path.

How to Tell Glaucoma Progression From Treatment Problems

SymptomWhat It SuggestsWhat To Do
Rising eye pressure with stable optic nervePossible adherence issueReview medication use and eye drop technique within weeks
Borderline visual field progressionInconsistent treatment or early progressionRepeat visual field testing and specialist review
Multiple missed doses each weekTreatment burdenSimplify regimen and reassess pressure
Burning or redness from medicationOcular surface toxicityReview medications and ocular surface health
Difficulty managing several bottlesCompliance challengeConsider fixed-dose combinations
Progressive optic nerve damage despite good adherenceTrue disease progressionDiscuss laser or surgical options with a glaucoma specialist

Why This Diagnosis Is So Often Missed

Doctors naturally focus on disease progression. Sometimes the treatment process receives less attention.

Eye pressure is easy to measure. Medication adherence is much harder to assess. Many patients feel embarrassed to admit they miss doses. Others genuinely believe they are using their medication correctly.

Busy clinics may not have time to observe eye drop technique. Treatment burden develops gradually. Patients adapt to it until the regimen becomes overwhelming.

Preservatives in glaucoma medications may also contribute to ocular surface disease. Redness, burning, and irritation can reduce adherence further.

When eye pressure rises, it is easy to assume the disease is worsening. Sometimes the medication is simply not reaching the eye consistently.

Recognising this distinction can prevent unnecessary treatment escalation.

When To See an Eye Specialist

You should seek specialist evaluation, or a second opinion, if:

  • You have been advised glaucoma surgery and want a second opinion
  • Eye pressure remains above target despite multiple medications
  • Your visual field tests show possible progression
  • You struggle to remember or administer your eye drops
  • Your eyes burn, sting, or remain red after glaucoma treatment
  • You have been told everything is stable but symptoms continue

Frequently Asked Questions

Can poor eye drop technique make glaucoma appear worse?

Yes. If medication does not reach the eye consistently, eye pressure may remain elevated. This can create the impression that treatment is failing even when the prescription itself is appropriate.

Why might a glaucoma specialist recommend a second opinion before surgery?

A second opinion helps confirm whether glaucoma is truly progressing. It also evaluates medication adherence, eye drop technique, treatment burden, and medication tolerance before irreversible procedures are considered.

How do fixed-dose combination eye drops help glaucoma patients?

Fixed-dose combinations reduce the number of bottles and simplify treatment schedules. This often improves adherence and helps patients maintain more consistent pressure control over time.

Should glaucoma surgery be delayed if treatment adherence is poor?

Not always. Some patients genuinely require surgery. However, adherence problems, poor eye drop technique, and unnecessarily complex regimens should be identified and addressed before concluding that surgery is the only option.

Book a Consultation

Consider a consultation if you have been advised glaucoma surgery, if your eye pressure remains uncontrolled, or if your visual field tests show possible progression despite treatment.

A glaucoma consultation includes assessment of optic nerve health, visual field results, pressure trends, medication tolerance, and practical evaluation of how glaucoma medications are being used.

[Book an Appointment →+91 8882638735]


This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated?, More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?

You may also want to read Glaucoma Second Opinion — Gurgaon, Online Glaucoma Consultation and Second Opinion Before Eye Surgery.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

HOW TO DO VISUAL FIELD

A visual field test checks your side (peripheral) vision and helps detect or monitor glaucoma and other optic nerve conditions. During the test, you look straight ahead and press a button whenever you notice lights appearing in different parts of your vision.

Automated static perimetry is the clinical gold standard for tracking glaucoma progression. Yet it is notoriously anxiety-inducing. High fixation losses and false positives corrupt diagnostic data when a patient is stressed. Active coaching before and during the test stabilises fixation, yields clean reproducible data, and transforms a feared exam into a collaborative clinical tool.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


How Patient-First Coaching Transforms Glaucoma Perimetry

Ask any glaucoma patient what part of their routine checkup they dread most. Nine out of ten will say the visual field test.

Sitting alone in a dark room, staring at a central yellow light, clicking a button for faint flashes you think you might be missing — it feels less like a diagnostic test and more like a high-stakes exam you are destined to fail.

A patient recently left a review that captured exactly why we approach this differently. They noted how other clinics seat you in the machine and tell you to press the clicker. No explanation. No preparation. Just anxiety and confusion. They described how, in our clinic, the entire experience was different. We walked them through what the visual field map actually shows. We explained the rhythm of the test before they started. They felt like a partner in their own care — not a passive subject.

You can read their experience here on Google.

When a patient understands that missing some flashes is a normal part of the machine’s threshold calculation, their heart rate drops. Their blinking stabilises. Their anxiety disappears.

That extra ten minutes of human coaching does not just produce a more comfortable patient. It produces pristine, accurate diagnostic data — the data we rely on to protect their optic nerve for decades.

What Actually Happens During a Visual Field Test

You sit with one eye covered and rest your chin on the machine. Your job is simple: keep looking at the central target and press the button whenever you notice a light anywhere in your side vision.

You are not expected to see every flash.

In fact, the machine deliberately presents lights that become increasingly faint to identify the threshold where vision transitions from “seen” to “not seen.” Missing some lights is not failure — it is how the test works.

Blink normally. Take short pauses if needed. If your attention drifts for a moment, do not panic and start clicking rapidly to catch up. The best visual field tests are usually not the fastest tests. They are the calmest.


The Most Common Mistake Patients Make

Patients often believe this is an intelligence test or a reaction-time test.

It is neither.

Trying too hard can sometimes reduce accuracy. Clicking every time you think a light might have appeared creates false positives. Chasing missed flashes leads to fatigue and fixation loss.

The goal is not perfection. The goal is honest responses.


Why One Visual Field Rarely Tells the Whole Story

A visual field is not interpreted in isolation.

Sleep, dry eye, anxiety, distraction, cataract, learning the machine, and even understanding instructions can influence a result.

That is why glaucoma decisions are usually made by combining visual fields with optic nerve examination, eye pressure, imaging, and change over time.

Protecting vision is rarely about one dramatic test result. It is about recognising patterns early and responding before change becomes irreversible.


This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated?, More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?


FAQs

How do I prepare for a visual field test?

No special preparation is usually needed. Wear your glasses if advised, stay relaxed, and try to rest your eyes before the test.

Is a visual field test painful?

No. A visual field test is non-contact, painless, and usually takes only a few minutes for each eye.

Why do visual field tests need to be repeated?

Visual field tests help monitor change over time. In glaucoma, repeated tests are often more useful than a single result because they help detect progression early.

Why is the visual field test for glaucoma so stressful?

The test is designed to find the absolute limit of your peripheral vision. It presents flashes that are intentionally very faint, so feeling like you are missing lights or guessing is completely normal. This design triggers anxiety when the process is not explained beforehand. Preparation changes the entire experience.

How does anxiety affect the accuracy of a glaucoma perimetry test?

High anxiety leads to irregular blinking, rapid head movements, and false-positive clicking. These introduce significant noise into the results. An ophthalmologist cannot reliably distinguish true disease progression from a stressful test day. A coached, relaxed patient produces far more clinically reliable data.

What if I think I did badly on my visual field test?

Many patients feel they performed poorly, especially during early tests. A difficult test does not automatically mean glaucoma has worsened. Ophthalmologists interpret reliability measures, compare previous results, and look for repeatable patterns over time.

Am I Doing My Visual Field Test Wrong?

Most patients worry they are doing badly because they miss flashes or feel uncertain during the test. That feeling is normal. Visual field testing is designed to find the edge of what you can see, so missing lights is expected and does not mean you have failed.

Why Do I Keep Missing Lights on My Glaucoma Test?

The machine deliberately shows lights that become fainter and fainter to calculate your visual threshold. Missing some lights helps the test work properly. Trying to click for every possible flash often makes results less reliable than staying relaxed and responding naturally.


Read about the full spectrum of glaucoma diagnosis and treatment. To know more about visual fields, read What to Expect and What the Results Mean, How To Do Visual Fields, Glaucoma Test Results Explained: OCT, Visual Fields and Eye Pressure, Why Do I Need a Visual Field.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Glaucoma Care in Gurgaon

Dr Shibal Bhartiya is an experienced glaucoma specialist in Gurugram, providing comprehensive diagnosis, personalised treatment, and expert second opinions for simple and complex glaucoma. Her evidence-based approach combines advanced diagnostics with long-term strategies to preserve vision. The L.I.F.T.S.™ Framework, devised by Dr Bhartiya, is a comprehensive diagnostic pathway that helps guide evidence-based glaucoma management and lifelong vision preservation. The framework follows five structured steps: Longitudinal Record Integration, Independent Diagnostic Re-Evaluation, Functional Rate-of-Progression Analysis, Target IOP & Lifetime Risk Profiling, and Proportional & Sustainable Management Planning.

Glaucoma is the leading cause of irreversible blindness worldwide. It is a progressive optic nerve disease that can silently damage vision much before symptoms become obvious. Early diagnosis, OCT imaging, visual field testing, and long-term monitoring are essential to reducing the risk of irreversible vision loss.

Superspecialty glaucoma care means catching that damage early, tracking it precisely, and making treatment decisions that are built around your individual risk, not a standard protocol.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google

Glaucoma Care in Gurgaon: Diagnosis, Treatment, and Second Opinions

Most people who arrive at a glaucoma consultation did not expect to be there.

Perhaps a routine eye check flagged your optic nerve. Maybe a parent lost vision to glaucoma and you want to know your own risk. Perhaps you have been on drops for years and something still doesn’t feel right. Whatever brought you here, you are asking the right question at the right time, because in glaucoma, timing is everything.

The nerve fibres that glaucoma destroys do not regenerate. Vision lost to this disease does not return. But vision that has not yet been lost can almost always be protected, if the disease is identified accurately, monitored carefully, and managed by a specialist with the training to interpret what the tests are actually showing.

This is what superspecialty glaucoma care means in practice.


What Glaucoma Actually Is

Glaucoma is not a single disease. It is a family of conditions that share one defining feature: progressive damage to the optic nerve, the cable that carries visual information from your eye to your brain.

In most forms of glaucoma, elevated intraocular pressure — the fluid pressure inside the eye — is the primary driver of that damage. But pressure is not the whole story. Roughly a third of glaucoma patients have pressures that fall within the normal range. In these patients, the nerve is vulnerable for reasons that go beyond simple mechanics — vascular supply, structural anatomy, and systemic factors all play a role.

This is why glaucoma cannot be managed by pressure alone. It requires a trained eye on the nerve itself.

The most common forms of glaucoma

Primary open-angle glaucoma is the most prevalent form globally and in India. It develops slowly, painlessly, and without warning. By the time peripheral vision is affected, significant nerve damage has usually already occurred.

Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures in the normal range are often reassured and discharged — while damage continues. Identifying this condition requires looking beyond the pressure reading.

Angle-closure glaucoma is more common in Asian populations. It can present as a sudden, painful emergency — or develop slowly and silently in the chronic form. A detailed anterior segment assessment is essential to detect the anatomical risk before a crisis occurs.

Childhood and secondary glaucomas require specialist evaluation. Secondary glaucomas — arising from inflammation, steroid use, trauma, or systemic conditions — are frequently missed or mismanaged without subspecialty input.


Why Superspecialty Training Changes Outcomes

A general ophthalmologist is trained to detect glaucoma and initiate treatment. A fellowship-trained glaucoma subspecialist is trained to do something more precise: to distinguish true progression from test variability, to select the right intervention at the right disease stage, and to manage the full complexity of a condition that evolves over decades.

The difference becomes most visible in three situations.

When the diagnosis is uncertain. Glaucoma suspects — patients with suspicious optic nerves or borderline pressures who do not yet meet diagnostic criteria — require careful longitudinal monitoring. The decision of when to treat, and how aggressively, requires experienced clinical judgement.

When progression occurs despite treatment. Patients who worsen on drops are not simply non-compliant. They may have nocturnal pressure spikes, inadequate pressure targets, or structural vulnerability that requires a different therapeutic approach entirely.

When surgery is on the table. The glaucoma surgical landscape has changed significantly with the advent of MIGS — minimally invasive glaucoma surgery. Knowing when MIGS is appropriate, which device fits which patient, and when conventional filtration surgery remains the better option requires a surgeon who operates across the full spectrum.


What to Expect at This Practice

My approach to glaucoma care is built around four principles. My practice at my clinic in Gurgaon, centres around these:

Catch it before it matters. Early detection requires looking beyond the standard pressure check — at the optic nerve structure, the retinal nerve fibre layer on OCT, and the visual field pattern over time. I look for the signal before the symptom.

Track it with precision. A single test is a photograph. Glaucoma management requires a series of photographs — read by someone who understands what change looks like, and what normal variation looks like. I review trends, not snapshots.

Treat it at the right stage. Not every glaucoma patient needs surgery. Not every glaucoma patient can be managed on drops alone. The treatment plan is built around your disease stage, your lifestyle, your pressure target, and your individual risk of progression.

Protect the ocular surface. Long-term glaucoma drops affect the surface of the eye in a significant proportion of patients. Ocular surface disease reduces comfort, affects adherence, and is frequently undertreated. I address it as part of glaucoma management — not as a separate problem.

📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults


Glaucoma Care Covered in This Practice

Diagnosis and Detection

Medical Management

Monitoring and Progression

Surgery

Local and General


When to Come In

Book a superspecialty consultation if any of the following apply:

  • You have been told your optic nerve looks “suspicious” or “cupped”
  • You have a parent or sibling with glaucoma
  • You are on glaucoma drops and have never had a formal progression assessment
  • Your visual fields are worsening despite treatment
  • You have been recommended surgery and want a second opinion
  • You have high myopia — a significant independent risk factor for glaucoma
  • You use steroid drops, inhalers, or nasal sprays regularly

Glaucoma does not announce itself. By the time you notice something is wrong, the window for easy intervention may already be narrowing. Early assessment costs very little. Late diagnosis costs vision.


Book a Consultation

If you’ve been diagnosed with glaucoma, told you may need laser or surgery, or simply want reassurance that your treatment is appropriate, I’d be happy to help. During your consultation, I’ll carefully review your history, examine your eyes, interpret your investigations, and explain your diagnosis and treatment options in clear, practical terms. Together, we’ll develop a personalised plan focused on preserving your vision for the long term.

Book a consultation for a comprehensive glaucoma evaluation or an expert second opinion.

📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults


Frequently Asked Questions

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed a dedicated fellowship — one to two years of focused training in glaucoma diagnosis, medical management, laser, and surgery — beyond standard ophthalmology residency. This training matters most in uncertain diagnoses, complex progression, and surgical planning.

How often should I have my eyes checked if I have glaucoma?

Most patients with established glaucoma require review every three to six months, including IOP measurement, OCT, and periodic visual field testing. The exact frequency depends on your disease stage, stability, and treatment response. Suspects require annual or biannual monitoring.

Can glaucoma be cured?

Glaucoma cannot currently be cured — but in the vast majority of patients, it can be controlled well enough to preserve functional vision for life. The key is early detection, accurate monitoring, and treatment that is adjusted as the disease evolves.

Is glaucoma hereditary?

Yes. First-degree relatives of glaucoma patients have a four to nine times higher risk of developing the condition. Screening siblings and adult children of affected patients is one of the most cost-effective interventions in glaucoma prevention.

What is MIGS and am I a candidate?

MIGS — minimally invasive glaucoma surgery — is a family of procedures designed to lower eye pressure with a safer profile than traditional filtration surgery. It is most appropriate for mild to moderate glaucoma. Not every patient is a candidate; appropriate selection requires subspecialty assessment.

You may want to listen to Dr Bhartiya answer some frequently asked questions here.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1600+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID | Github

📋Upload your reports for a structured review.| 🌐 Contact Us| 📞 +91 88826 38735

Helped by this article? Leave a Google review — it helps other patients find reliable eye care.


Here are some patient stories

The English Teacher Who Began Painting Again

How to do visual fields

Uveitic glaucoma

When Glaucoma Keeps Progressing

If glaucoma appears to be getting worse despite treatment, it does not necessarily mean that treatment has failed. Progression may occur because eye pressure is still too high for your optic nerve, eye pressure fluctuates between visits, medications are not being absorbed consistently, or another eye or neurological condition is affecting the optic nerve. The first step is to confirm that true progression has occurred before changing treatment.

When Glaucoma Keeps Progressing Despite Treatment: Causes, Next Steps and When to Seek a Second Opinion

Glaucoma can progress even with treatment. The most common reasons include suboptimal IOP control, non-adherence to drops, normal-tension progression, and unrecognised structural risk factors. Finding the cause and adjusting treatment early can prevent further vision loss, says Dr Shibal Bhartiya.

Glaucoma progresses in some patients despite regular treatment. This does not mean the treatment has failed, it means the treatment plan needs review.

Understanding why glaucoma advances is the first step toward stopping it. Several factors can drive progression even when eye pressure appears controlled.

If glaucoma is progressing…What usually happens next
Confirm progressionCompare OCT, visual fields and photographs
Review eye pressureTarget pressure may need to be lower
Review medicationsCheck technique and adherence
Look for other causesNot every damaged optic nerve is glaucoma
Discuss treatmentLaser, additional drops or surgery if required

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

What Does Progression Mean in Glaucoma?

Progression means measurable worsening of the optic nerve or visual field over time. Specialists confirm it using two or more reliable visual field tests and OCT imaging showing thinning of the retinal nerve fibre layer.

A single abnormal test does not confirm progression. Consistent change across multiple visits does.

Why Glaucoma Progresses Despite Drops

1. Eye Pressure Is Still Too High

The target intraocular pressure (IOP) is individual. A pressure that seems normal may still be too high for a given optic nerve. Studies show that lower IOP targets reduce progression rates in moderate and advanced glaucoma significantly.

If visual fields are worsening, the current pressure target may need revision downward.

2. Drops Are Not Working as Expected

Peak pressure often occurs in the early morning, outside clinic hours. A single office reading may miss harmful pressure spikes. Diurnal IOP curves — tested over several hours — can reveal fluctuations that drive unseen damage.

3. Non-Adherence to Eye Drop Therapy

Studies using electronic monitoring show that patients use drops correctly only 50 to 70 percent of the time. Missing doses, incorrect technique, or preservative intolerance all reduce drug efficacy. Non-adherence is the most correctable cause of progression.

4. Normal-Tension Glaucoma Behaving Differently

Some patients have optic nerve damage at pressures within the normal range. This is normal-tension glaucoma (NTG). It may involve poor vascular supply to the nerve, sleep apnoea, low blood pressure at night, or other systemic factors that drops alone cannot address.

5. Structural Risk Factors Not Yet Addressed

Thin corneas cause IOP readings to appear falsely low. A myopic or tilted optic disc is harder to interpret on imaging. Disc haemorrhages are a strong marker of ongoing progression and must be documented carefully.

6. Systemic Factors Affecting the Optic Nerve

Low systolic blood pressure, anaemia, sleep apnoea, and vascular disorders can reduce blood flow to the optic nerve. Treating these conditions alongside glaucoma can slow visual field loss in susceptible patients.

Reason for ProgressionWhat It MeansNext Step
IOP target not low enoughNerve still under excess pressureLower target IOP or add therapy
Pressure spikes between visitsDiurnal fluctuation causing damageDiurnal IOP curve or 24-hour monitoring
Drop non-adherenceInconsistent pressure loweringTechnique review, preserve-free drops, fixed combos
Normal-tension glaucomaVascular or non-pressure mechanismSystemic workup, cardiology review
Thin cornea or high myopiaIOP underestimated by tonometryCorneal-corrected IOP, adjusted targets
Disc haemorrhageActive ischaemia at optic nerveClose follow-up, often signals rapid progression
Systemic comorbidityPoor vascular supply to nerveTreat sleep apnoea, anaemia, hypotension

Why Can Glaucoma Progress Despite “Normal” Eye Pressure?

Many patients are surprised to learn that glaucoma can sometimes worsen even when the eye pressure appears to be “normal.” The reason is simple: normal is not the same as safe.

Every eye has its own target pressure—the pressure at which further damage to the optic nerve is unlikely to occur. For some people, a pressure of 18 mmHg may be perfectly safe, while for others, even 12 mmHg may be too high. As glaucoma progresses, the target pressure often needs to be lowered further.

Some people develop normal-tension glaucoma, where optic nerve damage occurs despite eye pressures that fall within the normal range. Others may experience pressure fluctuations that are missed during routine clinic visits, or pressure spikes that occur at night, when eye pressure is not usually measured.

In addition, factors such as reduced blood flow to the optic nerve, low blood pressure during sleep, migraine, or other vascular conditions may make the optic nerve more vulnerable to damage, even when pressure is well controlled. Finally, some forms of glaucoma are simply more aggressive and continue to progress despite apparently adequate treatment.

If glaucoma appears to be worsening despite “normal” eye pressure, it does not necessarily mean treatment has failed. It often means that your eye may require a lower target pressure, closer monitoring, or a reassessment of the diagnosis and treatment plan.

When to Consider Laser or Surgery

If maximum tolerated medical therapy does not achieve the revised IOP target, laser trabeculoplasty (SLT) or surgery becomes necessary. Selective laser trabeculoplasty is effective in open-angle glaucoma and can reduce the drop burden significantly.

Minimally invasive glaucoma surgery (MIGS) procedures such as iStent and iStent inject offer an option for mild to moderate glaucoma with lower surgical risk. Trabeculectomy remains the benchmark for advanced disease requiring very low pressures.

Dr Shibal Bhartiya’s published research includes peer-reviewed work on 24-hour IOP monitoring and diurnal pressure fluctuation: one of the most under-recognised drivers of progression in treated glaucoma. She has co-authored guidelines on surgical decision-making when medical therapy fails to halt optic nerve damage. As Clinical Director of Ophthalmology at Marengo Asia Hospitals, Gurugram, she manages complex progression cases with a structured protocol: reassess the IOP target, confirm adherence, evaluate vascular and systemic risk, and escalate to laser or surgery when the nerve continues to lose ground.

Book an Appointment

📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults

How Often Should You Be Reviewed?

Patients with progressing glaucoma need more frequent review — often every three to four months. Visual fields should be repeated at least four times a year if progression is suspected. OCT of the optic nerve head and RNFL should accompany each visit.

Waiting six or twelve months between visits when progression is active is not safe practice.

The Role of a Second Opinion

Glaucoma management decisions are complex. If your visual fields continue to worsen, a second opinion from a fellowship-trained glaucoma specialist adds value. Fresh eyes on your imaging, IOP pattern, and structural data can identify a missed cause.

Bringing your previous visual fields, OCT scans, and medication list to the consultation helps the specialist assess the rate of change accurately.

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

Book a Consultation

If your glaucoma appears to be progressing despite treatment, it is important not to assume that vision loss is inevitable—or that more treatment is always the answer. The first step is to determine whether true progression has occurred and, if so, why.

During your consultation, I will carefully review your previous OCT scans, visual field tests, optic nerve photographs, eye pressure records, medications, and overall clinical history. My aim is to identify the underlying reason for progression, confirm whether your current target eye pressure is appropriate, and recommend a personalised treatment plan based on the best available evidence.

Whether you have recently been diagnosed with glaucoma, have been advised to undergo laser or surgery, or would simply like an expert second opinion, a comprehensive assessment can help ensure that treatment decisions are based on the complete clinical picture—not a single test or eye pressure reading.

Book a consultation for an evidence-based glaucoma evaluation and a personalised plan to help preserve your vision over the long term.

📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults

What Happens If Your Glaucoma Appears to Be Progressing?

If glaucoma seems to be worsening despite treatment, the first step is not to rush into changing medications or recommending surgery. It is important to confirm that true progression has occurred and understand why.

Your consultation usually begins with a detailed review of your symptoms, medical history, and any changes since your last visit. We discuss how regularly you are using your eye drops, whether the technique is correct, and whether you have experienced any side effects or difficulties with treatment.

Next, we compare your current OCT scans with previous ones to look for changes in the retinal nerve fibre layer or optic nerve over time. Your visual field tests are analysed for long-term trends rather than relying on a single test, since natural variability can sometimes mimic progression.

Careful examination of the optic nerve, often using serial optic nerve photographs, helps identify subtle structural changes that may not be obvious during routine examination. Gonioscopy is performed when necessary to reassess the drainage angle and ensure that no additional angle abnormalities or secondary causes of glaucoma have developed. Corneal thickness (central corneal thickness) is also reviewed, as it influences both the accuracy of eye pressure measurements and the target pressure appropriate for your eye.

Only after considering all these findings together do we decide whether treatment needs to change. This may involve lowering your target eye pressure, improving medication adherence, adding or changing eye drops, recommending laser treatment, or discussing glaucoma surgery. The goal is not simply to reduce the eye pressure, but to preserve your vision for the rest of your life.

Progression does not mean blindness

Remember:

  • glaucoma progression is common
  • treatment plans evolve
  • many patients need additional treatment over time
  • progression detected early is usually manageable
  • the aim is lifetime vision, not today’s pressure

Frequently Asked Questions

Can glaucoma progress even with normal eye pressure?

Yes. Normal-tension glaucoma progresses at IOP readings within the statistical normal range. The optic nerve in these patients is more sensitive to pressure or more dependent on blood supply. Treatment often involves additional systemic assessment alongside IOP lowering.

How do I know if my glaucoma is progressing?

Your specialist tracks visual field tests and OCT scans over time. Progression is confirmed when two or more reliable tests show consistent worsening. You may not notice early progression — which is why regular monitoring matters.

What pressure should I aim for if my glaucoma is progressing?

The target varies by disease severity and rate of progression. Advanced or rapidly progressing glaucoma typically requires a target below 12 mmHg. Your specialist calculates this based on your structural damage and life expectancy.

Are there lifestyle changes that help slow progression?

Regular aerobic exercise, avoiding head-down positions such as headstands, good sleep hygiene, and managing vascular risk factors all support optic nerve health. Omega-3 supplementation and antioxidant nutrition are areas of ongoing research.

Is surgery the only option if drops stop working?

Not always. Selective laser trabeculoplasty is a non-incisional option that works well in many patients. If laser is not sufficient, MIGS procedures offer a middle path between drops and conventional surgery.

Consult a Glaucoma Specialist

If your glaucoma is progressing despite treatment, you need a specialist review, not just a medication change. The cause must be identified before the right intervention can be chosen.

About the Author

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1600+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

📋Upload your reports for a structured review.| 🌐 Contact Us| 📞 +91 88826 38735

Helped by this article? Leave a Google review — it helps other patients find reliable eye care.

Related Reading

Get an Online Glaucoma Consult

Visual Field and OCT: Structure & Function Correlation

Glaucoma Diagnosis in Gurgaon

Risk Stratification in Glaucoma

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon